STUDY TO ASSESS SAFETY AND PK PROFILE OF IBUPROFEN SUSPENSION

• Research type

  Research Study

• Full title

  Single-dose, 3-Period Crossover, Open-Label, Randomized Study in Healthy Volunteers to Assess the Safety and Pharmacokinetic Profile of 2 oral formulations of Ibuprofen Suspension based on Liquitime® Technology, and The Marketed Reference Product

• IRAS ID

  155487

• Contact name

  Brendan Colgan

• Contact email

  brendan.colgan@celerion.com

• Eudract number

  2014-000512-34

• REC name

  HSC REC B

• REC reference

  14/NI/0077

• Date of REC Opinion

  5 Jun 2014

• REC opinion

  Further Information Favourable Opinion